Previous Nav
Net Change on 29-09-2023
PersonalFN Rating
Category
Assets (Cr.)
Expense Ratio
Fund House
Launch Date
Benchmark
Minimum Investment (₹)
Minimum Addl Investment (₹)
Exit Load (%)
Minimum SIP Investment (₹)
Minimum STP Investment (₹)
Minimum SWP Investment (₹)
52 Week Low Nav (₹)
52 Week Low Nav Date
52 Week High Nav (₹)
52 Week High Nav Date
Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised
Sun Pharmaceutical Industries Limited
Cipla Limited
Dr. Reddy's Laboratories Limited
Max Healthcare Institute Limited
Lupin Limited
Torrent Pharmaceuticals Limited
Suven Pharmaceuticals Limited
Apollo Hospitals Enterprise Limited
Alkem Laboratories Limited
Aurobindo Pharma Limited
Laurus Labs Limited
Mankind Pharma Limited
Syngene International Limited
Zydus Lifesciences Limited
Divi's Laboratories Limited
FDC Limited
JB Chemicals & Pharmaceuticals Limited
Natco Pharma Limited
Vishnu Chemicals Limited
Gland Pharma Limited
Alembic Pharmaceuticals Limited
Astec LifeSciences Limited
Ajanta Pharma Limited
Net Receivables / (Payables)
Metropolis Healthcare Limited
Healthcare Global Enterprises Limited
Sanofi India Limited
Rainbow Childrens Medicare Limited
Abbott India Limited
Sun Pharma Advanced Research Company Limited
Ami Organics Limited
Fortis Healthcare Limited
Gujarat Fluorochemicals Limited
Vijaya Diagnostic Centre Limited
Sequent Scientific Limited
Dr. Lal Path Labs Limited
TTK Healthcare Limited
Pharmaceuticals & Drugs
Hospital & Healthcare Services
Miscellaneous
Chemicals
Pesticides & Agrochemicals
Cash
Equity
ITI Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to ITI Mutual Fund. It was launched on 08-Nov-2021 and currently has an AUM of ₹137.95 crore. ITI Pharma & Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and Nifty Healthcare Index - TRI as secondary index.
The NAV of ITI Pharma & Healthcare Fund ended up ₹0.18(1.62%)yesterday to ₹11.096.
Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and
The ITI Pharma & Healthcare Fund is managed by Dhimant Shah and Rohan Korde.
ITI House, 36, R K Shirodkar Marg, Parel Mumbai - 400 012